ZEMIGLO 50MG TABLET contains Gemigliptin which belongs to the group of medicines called Antidiabetic agents. It is used as an adjunct to the diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus, as an monotherapy or in combination with metformin in patients with inadequate glycemic control on metformin alone.
Diabetes mellitus is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys, and nerves. ZEMIGLO 50MG TABLET is not recommended in patients with type 1 diabetes, diabetic ketoacidosis. Before taking inform your doctor if you have pancreatitis, liver, kidney or heart problems.
Inform your doctor before taking ZEMIGLO 50MG TABLET if you are pregnant or breastfeeding women. The common side effects of taking this medicine are headache, urinary tract infection and diarrhea. Consult your doctor if any of the above side persists for a longer duration.
No content available
